Opus8

Opus8, Inc. is a private equity and venture capital firm based in Chevy Chase, Maryland, with an additional office in Shanghai, China. Founded in 2002, the firm specializes in middle market buyouts and early-stage investments, focusing primarily on sectors such as business process outsourcing, information technology, consumer products, financial services, healthcare, and media. Opus8 seeks to invest in companies with annual revenues of at least $5 million in nutraceuticals and $20 million in business services, typically preferring opportunities that show significant growth potential. The firm is particularly interested in well-managed companies that can benefit from offshoring, improved customer relationship management, and the sale of intellectual assets. Opus8 typically invests up to $1 million in the form of convertible debentures or redeemable preferred stock and may hold investments for seven to ten years. Additionally, the firm offers advisory services and organizes exclusive conferences and trade missions in collaboration with the U.S. government.